CVS Health CFO Thomas Cowhey to Exit Amid Turnaround Efforts

CVS Health (NYSE:CVS) Chief Financial Officer Thomas Cowhey is preparing to step down, according to a Bloomberg News report citing sources familiar with the matter. The timing of his departure remains uncertain, and no official reason has been disclosed.

Cowhey was named CFO in January 2024 after serving in the role on an interim basis since October 2023. His planned exit comes as CVS undergoes a significant corporate restructuring under new CEO David Joyner, who was appointed last October amid mounting financial pressures and investor concerns.

The healthcare giant has struggled in recent years, missing earnings expectations for the first three quarters of 2024 and ultimately withdrawing its full-year guidance upon Joyner’s appointment. In response, Joyner introduced aggressive cost-cutting measures and appointed a new head of the company’s insurance division to help steer the business through what is being called one of the most challenging times in CVS’s 60-year history.

Despite earlier setbacks, CVS managed to beat Wall Street estimates in its fourth-quarter earnings report released in February and provided an annual forecast that met most analysts’ expectations. However, the company remains under scrutiny as it works to regain investor confidence and improve operational efficiency.

CVS declined to comment on Cowhey’s exit and did not immediately respond to requests from Reuters.

As one of the largest health insurers and pharmacy chains in the U.S., CVS’s leadership changes and financial performance are closely watched by analysts and shareholders alike. Cowhey’s departure signals another chapter in the company’s ongoing turnaround strategy as it navigates a rapidly evolving healthcare landscape.